| Particulars |
|
|
|
| Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
115.10 |
| Sales(₹ Cr.) |
3,723.49 |
NP (₹ Cr.) |
865.43 |
| NP Var% |
33.00 |
Div% |
540.00 |
| CPS(₹) |
55.00 |
EPS (₹) |
51.10 |
| Traded Value(₹ Lakhs) |
51.03 |
52 Week High |
3,516.00 |
| 52 Week Low |
1,924.00 |
Price BSE |
3,200.00 |
| Price NSE |
3,199.00 |
Market Capital (₹ Cr.) |
54,208.24 |
| P/C Ratio |
58.20 |
P/E Ratio |
62.60 |
| Price Vs.BV |
27.80 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
966.08 |
| NP(₹ Cr.) |
260.14 |
NP Var % |
36.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
3,526.90 |
| OPM |
-5.85 |
NP |
795.84 |
| NP Var% |
32.88 |
EPS |
51.09 |
| PE |
62.63 |
|
|